ImmunityBio, Inc.

NASDAQ:IBRX

Biotechnology

Healthcare
$6.57 +2.58%

+$0.18 today

Market cap
$6.99B
Beta
0.10
P/E (TTM)
-8.6
EPS (TTM)
-$0.83
52W Low $1.95High $12.43

Volume 11.10M

Average 16.40M

Price history

ImmunityBio, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+225.25%

Period high

$11.55

Period low

$1.98

Latest

$6.57

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 9, 2026Nov 9, 2026
8-KNov 9, 2026Nov 9, 2026
8-KNov 9, 2026Nov 9, 2026
8-KOct 14, 2026Oct 14, 2026
4Oct 6, 2026Oct 6, 2026
4Oct 6, 2026Oct 6, 2026
SC 13D/AAug 6, 2026Aug 6, 2026
8-KAug 4, 2026Aug 4, 2026
10-QAug 4, 2026Aug 4, 2026
8-KJul 30, 2026Jul 30, 2026
4Jul 6, 2026Jul 6, 2026
4Jul 6, 2026Jul 6, 2026
4Jul 1, 2026Jul 1, 2026
4Jun 26, 2026Jun 26, 2026
4Jun 10, 2026Jun 10, 2026

Competitors

Who does ImmunityBio, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about IBRX's filings, answered from its disclosures.

What is the latest IBRX filing?

The latest filing shown is 10-Q dated Nov 9, 2026.

How many recent filings does IBRX have?

Intrinsic Alpha currently shows 20 recent filings for IBRX.